LSTA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Lisata Therapeutics, Inc. is Fair to Shareholders

Core Viewpoint - Halper Sadeh LLC is investigating the fairness of the sale of Lisata Therapeutics, Inc. to Kuva Labs, Inc. for $4.00 per share in cash plus two non-tradeable contingent value rights [1] Group 1 - The sale price of $4.00 per share is being scrutinized for its fairness to Lisata shareholders [1] - The transaction includes two non-tradeable contingent value rights that are payable under certain conditions [1] - Lisata shareholders are encouraged to explore their legal rights and options regarding the sale [1]